Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)



NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)


NT trends in ecstasy and related drug markets; Reports; PublicationNT




Made available via the Publications (Legal Deposit) Act 2004 (NT).


Date:2011; Australian drug trends series No. 80




Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)



Copyright owner

Check within Publication or with content Publisher.

Parent handle


Citation address


Page content

26 continued to be the most popular form of morphine, that there were occasional reports of use of illicit Physeptone and that there were rare reports of illicit methadone syrup use. She added that there were more regular reports of illicit Suboxone use, with report rates similar to those for Physeptone tablets. She also stated that opiate users were developing greater knowledge of pharmacology and referred to reports of users taking Suboxone (unsupervised) to withdraw from morphine. A KE commented that morphine users in Darwin were a distinct group and were often unemployed or on a disability support pension. 4.7 Other drugs Key Points Nine percent of participants reported ecstasy use (on a median of two days) in the preceding six months, a slight reduction from the 10% who reported ecstasy use in the preceding six months in 2010. Any form of benzodiazepines (illicit and/or licit) was used by 61% of participants in the preceding six months, a significant increase from the 52% who reported recent use in 2010. Thirty-six percent of participants had recently used illicit Alprazolam and 13% had recently used licit Alprazolam. Recent use of any form of pharmaceutical stimulants increased to 12% of participants (6% in 2010) on a median of 5 days. Hallucinogens were used by 7% of participants in the preceding six months, on a median of three days. Five participants reported recent use of any form of Seroquel. Sixty-three percent of participants reported use of alcohol in the preceding six months, on a median of 24 days. No participants reported use of inhalants in the preceding six months. Daily use of tobacco increased to 97% of participants. 4.7.1 Ecstasy Figure 10 illustrates that recent reported ecstasy use continued to decline in 2011, with 9% reporting use within the past six months (10% in 2010 and 20% in 2009) and no respondents reporting injection of the substance (4% in 2010 and 10% in 2009).

Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.